↓ Skip to main content

Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor

Overview of attention for article published in Frontiers in oncology, October 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Estrogen Receptor Beta (ERβ): A Ligand Activated Tumor Suppressor
Published in
Frontiers in oncology, October 2020
DOI 10.3389/fonc.2020.587386
Pubmed ID
Authors

Rahul Mal, Alexa Magner, Joel David, Jharna Datta, Meghna Vallabhaneni, Mahmoud Kassem, Jasmine Manouchehri, Natalie Willingham, Daniel Stover, Jeffery Vandeusen, Sagar Sardesai, Nicole Williams, Robert Wesolowski, Maryam Lustberg, Ramesh K. Ganju, Bhuvaneswari Ramaswamy, Mathew A. Cherian

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 127 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 9%
Student > Ph. D. Student 9 7%
Student > Bachelor 9 7%
Researcher 8 6%
Student > Doctoral Student 6 5%
Other 14 11%
Unknown 69 54%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 15%
Medicine and Dentistry 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 7 6%
Neuroscience 5 4%
Chemistry 4 3%
Other 11 9%
Unknown 73 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2022.
All research outputs
#16,733,516
of 25,387,668 outputs
Outputs from Frontiers in oncology
#6,619
of 22,433 outputs
Outputs of similar age
#264,518
of 440,319 outputs
Outputs of similar age from Frontiers in oncology
#199
of 703 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,319 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 703 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.